AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study
Recruiting
Observational Study
Nasopharyngeal Neoplasms
Laryngeal Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Ruijin Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
An artificial intelligence-assisted system is trained and validated by collecting nasopharyngolaryngoscopy images from patients.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years;
* Underwent standard electronic nasopharyngolaryngoscopy;
* Patients who underwent biopsy sampling have a clear pathological diagnosis;
* Signed a written informed consent form.
Exclusion Criteria:
* Image quality is substandard with severe motion artifacts;
…
Contacts